// you’re reading...

General Biotechnology

Pfizer sues over counterfeit Lipitor

By Yali ⋅ June 5, 2003 ⋅ Email This Post Email This Post ⋅ Print This Post Print This Post ⋅ Post a comment

Pfizer sues over counterfeit Lipitor
Pfizer Inc. said Tuesday it was suing two companies connected to counterfeit versions of its cholesterol fighter, Lipitor, the world’s top-selling prescription medicine.

Print This Post

Discussion

No comments for “Pfizer sues over counterfeit Lipitor”

Post a comment

Building Biotechnology - Starting, Managing, and Understanding Biotechnology Companies   The Business of Biotechnology - Profit From the Growing Influence of Biotechnology
Best Practices in Biotechnology Business Development Best Practices in Biotechnology Education
Journal of Commercial Biotechnology 
DrugPatentWatch.com